Skip to main content

Table 4 Logistic regression analysis of the relationship between NAFLD on ultrasound and FSH according to gender and age stratification

From: Follicle-stimulating hormone is negatively associated with nonalcoholic fatty liver disease in a Chinese elderly population: a retrospective observational study

   

adjusted association

 

Unadjusted association

Model 1

Model 2

All

Odds ratios

0.991

0.981

0.979

95%CI

0.985–0.997

0.969–0.993

0.968–0.989

P value

0.003

0.002

< 0.001

Men*

N = 98

Odds ratios

0.971

0.859

0.937

95%CI

0.942-1.000

0.764–0.966

0.892–0.984

P value

0.046

0.011

0.009

Women*

N = 357

Odds ratios

0.981

0.980

0.982

95%CI

0.973–0.990

0.967–0.993

0.971–0.993

P value

< 0.001

0.003

0.002

Age stratification

    

between 60–70 years

Odds ratios

0.988

0.986

0.983

 N = 230

95%CI

0.979–0.996

0.969–1.003

0.967–0.999

 

P value

0.005

0.114

0.033

Over 70 years

Odds ratios

0.993

0.963

0.973

 N = 225

95%CI

0.985–1.002

0.943–0.984

0.958–0.989

 

P value

0.150

0.001

0.001

  1. Model 1 included age, gender, body mass index, systolic blood pressure, fasting blood glucose, triglycerides, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, alanine aminotransferase, aspartate aminotransferase, estradiol and testosterone for adjustment
  2. Model 2 included age, gender, alanine aminotransferase, aspartate aminotransferase, estradiol, testosterone, diabetes mellitus, dyslipidemia, obesity and hypertension for adjustment
  3. NAFLD: nonalcoholic fatty liver disease; FSH: follicle-stimulating hormone
  4. *: All variables except gender were included in the models